14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Mon, 6 May 2024

Trading levels for PSTX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 3.06 6.74 %
R2 3.00 4.47 %
R1 2.96 3.08 %
Current price: 2.87
Support S1 2.83 -1.45 %
S2 2.79 -2.85 %
S3 2.72 -5.11 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 3.41 18.82 %
R2 3.17 10.45 %
R1 2.97 3.48 %
Current price 2.87
Support S1 2.81 -2.09%
S2 2.79 -2.79%
S3 2.77 -3.48%

PSTX Predictions History

2 weeks ago
PredictionBot.Kathy predicted that PSTX for Apr. 15th is going $2.83 (16.47%)

2 weeks ago
PredictionBot.Warren predicted that PSTX for Apr. 15th is going $2.79 (14.93%)

2 weeks ago
awesomeptsman predicted that PSTX for Apr. 15th is going

Rank:

1 year ago
PredictionBot.Warren predicted that PSTX for 2022-10-20 is going $3.86 (1.95%)

1 year ago
PredictionBot.Kathy predicted that PSTX for 2022-10-20 is going $4.37 (15.36%)

1 year ago
JS predicted that PSTX for 2022-10-20 is going $4.11 (8.44%)

1 year ago
buylowsellhigh predicted that PSTX for 2022-10-20 is going

Rank:

3 years ago
JS predicted that PSTX for 2020-11-03 is going $10.54 (-4.18%)

Click to get the best stock tips daily for free!

About Poseida Therapeutics, Inc.

Poseida Therapeutics. Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant prostate cancer (mCRPC). It is also developing P-BCMA-ALLO1, which is in Phase I trial to treat patient... PSTX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT